Sharda Cropchem Q1FY27: Revenue up 9%, PBT down 30%

What changed for Sharda Cropchem this quarter

Sharda Cropchem Ltd reported a mixed set of numbers for Q1FY27, with operating revenue rising year-on-year but profitability and sequential performance seeing a sharp decline. The company’s consolidated revenue from operations increased 9.03% YoY to Rs 1,073.77 crore in Q1FY27, compared with Rs 984.81 crore in Q1FY26. But the same metric fell 48.00% quarter-on-quarter from Rs 2,064.90 crore in Q4FY26.

Profitability also softened. Consolidated profit before tax (PBT) came in at Rs 118.43 crore, down 30.00% YoY from Rs 169.14 crore in Q1FY26 and down 71.94% QoQ from Rs 422.08 crore in Q4FY26. Basic and diluted EPS for Q1FY27 stood at Rs 9.76, versus Rs 15.83 in Q1FY26 and Rs 35.32 in Q4FY26.

As of the update, the current share price of Sharda Cropchem was Rs 784.95.

Q1FY27 financial snapshot: revenue up, income down QoQ

On the income line, the company reported total consolidated income of Rs 1,108.29 crore for Q1FY27. This was 8.94% higher than Rs 1,017.30 crore in Q1FY26, but 46.90% lower than Rs 2,087.35 crore in Q4FY26.

The divergence between YoY growth and QoQ decline is visible across the key profit and income indicators shared. Q1FY27 reflects improvement over the same period last year, while also showing a substantial drop compared with the immediately preceding quarter’s base.

How Q4FY26 compared with earlier periods

The company’s Q4FY26 total income was Rs 2,087.35 crore. This represented a 59.34% QoQ increase over Q3FY26 total income of Rs 1,310.00 crore, and a 12.60% YoY increase over Q4FY25 total income of Rs 1,853.76 crore.

This context is important because Q1FY27’s QoQ decline is being measured against a stronger Q4 base on both income and profits. The provided figures show Q4FY26 also had much higher PBT (Rs 422.08 crore) and EPS (Rs 35.32) than Q1FY27.

FY26 annual performance: income and PAT rose YoY

For the full year, Sharda Cropchem’s annual total income for FY26 stood at Rs 5,373.13 crore, up 22.69% YoY from Rs 4,379.39 crore in FY25. Annual net profit (PAT) for FY26 was Rs 680.99 crore, rising 123.70% from Rs 304.42 crore in FY25.

Basic earnings per share for FY26 were reported at Rs 75.47, compared with Rs 33.74 in FY25. These annual numbers set the backdrop for the company’s dividend proposal and AGM agenda for FY26.

Additional quarterly metrics cited: revenue, EBITDA and margins

The data also includes operating metrics for select quarters expressed in crore. For Q3FY26, revenue was reported at Rs 1,288.8 crore versus Rs 929.3 crore in Q3FY25, a change of 39%. EBITDA for Q3FY26 was Rs 245.5 crore compared with Rs 154.2 crore in Q3FY25, a change of 59%, with EBITDA margin at 19.1% for Q3FY26.

For Q3FY25, revenue was Rs 929.3 crore compared with Rs 632.5 crore in Q3FY24, a 47% change. Gross profit in Q3FY25 was Rs 304.2 crore versus Rs 165.6 crore in Q3FY24, up 84%, and gross profit margin was 32.7% for Q3FY25.

For Q1FY25, revenue was Rs 785.1 crore (up 23% YoY), gross profit was Rs 228.9 crore (up 311% YoY), and gross profit margin was 29.2% (up from 8.7% in Q1FY24). EBITDA for Q1FY25 was Rs 88.3 crore, compared with negative Rs 66.0 crore in Q1FY24.

Board, results calendar, and the earnings call

The company had informed the BSE that a board meeting was scheduled on July 29, 2026, to consider and approve unaudited standalone and consolidated results. Separately, a schedule was also provided for the Q1FY27 earnings discussion.

The listed details for the earnings call were:

Dividend and AGM: key dates shareholders should track

Sharda Cropchem’s board recommended a final dividend of Rs 9.00 per equity share (face value Rs 10.00 each) for FY26, subject to shareholder approval at the AGM. The company fixed Friday, August 7, 2026 as the record date to determine eligibility for the final dividend for the financial year ended March 31, 2026. The dividend payout is subject to shareholder approval at the upcoming AGM.

The 23rd Annual General Meeting is scheduled for Friday, August 14, 2026 at 1:00 pm IST through video conferencing and other audio visual means, without physical presence at a common venue, in line with applicable MCA and SEBI circulars cited in the notice.

The company also disclosed book closure and e-voting timelines, including that proxy appointment will not be available because physical attendance has been dispensed with.

Director item on the AGM agenda

The AGM agenda includes the re-appointment of Mr. Ashish R. Bubna (DIN: 00945147), who retires by rotation and is eligible for re-appointment. Shareholders will also consider ordinary business including adoption of audited standalone and consolidated financial statements for FY26.

Market impact: what the disclosed numbers indicate

The reported figures point to two simultaneous signals. On a YoY basis, Q1FY27 shows growth in revenue from operations and total income, indicating higher activity compared with Q1FY26. On a QoQ basis, the steep decline from Q4FY26 is visible across revenue, income, PBT, and EPS, suggesting the quarter was significantly weaker than the immediately preceding period.

The dividend process adds near-term milestones for investors, with clear dates for record date, book closure, and e-voting. For market participants tracking corporate actions, the record date of August 7, 2026 is the key eligibility cutoff for the proposed final dividend of Rs 9 per share.

Why this matters: linking FY26 strength with Q1FY27 softness

The FY26 annual numbers show a strong year-on-year improvement in both total income (up 22.69%) and PAT (up 123.70%), alongside a higher FY26 EPS of Rs 75.47. Against that backdrop, the Q1FY27 print highlights that quarterly performance can vary significantly even after a strong full-year outcome.

The disclosures also show that Q4FY26 was a relatively strong quarter in terms of total income (Rs 2,087.35 crore) compared with Q3FY26 (Rs 1,310.00 crore), making Q1FY27’s sequential decline more pronounced when viewed solely through the QoQ lens.

Conclusion

Sharda Cropchem’s Q1FY27 results showed 9% YoY growth in revenue from operations to Rs 1,073.77 crore, while profitability weakened with PBT down 30% YoY to Rs 118.43 crore and EPS at Rs 9.76. Investors also have a defined calendar for the FY26 final dividend process, with the record date set for August 7, 2026 and the AGM scheduled for August 14, 2026 via VC/OAVM.